MIRA: MIRA Pharmaceuticals, Inc. Stock

by  •  • Comments Off on MIRA: MIRA Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 13.38
Enterprise Value ($M) 8.77
Book Value ($M) 4.37
Book Value / Share 0.30
Price / Book 3.06
NCAV ($M) 4.30
NCAV / Share 0.29
Price / NCAV 3.11

Profitability (mra)
Return on Invested Capital (ROIC) -2.71
Return on Assets (ROA) -30.14
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 8.70
Current Ratio 8.70

Balance Sheet (mrq) ($M)
Current Assets 4.86
Assets 4.93
Liabilities 0.56
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -8.53
Net Income -11.98

Cash Flow Statement (mra) ($M)
Cash From Operations -4.53
Cash from Investing 0.00
Cash from Financing 8.78

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
12-27 13D/A Bay Shore Trust 31.01 -4.64

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-09-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 1,346 818 164.55
2024-04-25 1,033 1,602 64.48
2024-04-24 5,638 2,561 220.15
2024-04-23 19,593 1,619 1,210.19
2024-04-22 3,858 5,033 76.65

(click for more detail)

Similar Companies
MBIO – Mustang Bio, Inc. MBRX – Moleculin Biotech, Inc.
MEIP – MEI Pharma, Inc. MLTX – MoonLake Immunotherapeutics
MNPR – Monopar Therapeutics Inc.


Financial data and stock pages provided by
Fintel.io